B. Riley Weighs in on InfuSystem's Q1 Earnings (NYSE:INFU)

InfuSystem Holdings, Inc. (NYSE:INFU - Free Report) - B. Riley issued their Q1 2026 earnings per share (EPS) estimates for shares of InfuSystem in a report released on Thursday, May 8th. B. Riley analyst A. Schock anticipates that the company will post earnings of $0.04 per share for the quarter. B. Riley has a "Strong-Buy" rating on the stock. The consensus estimate for InfuSystem's current full-year earnings is $0.15 per share. B. Riley also issued estimates for InfuSystem's Q2 2026 earnings at $0.06 EPS, Q3 2026 earnings at $0.09 EPS and Q4 2026 earnings at $0.11 EPS.

INFU has been the topic of several other research reports. Sidoti raised InfuSystem to a "strong-buy" rating in a research note on Tuesday, March 18th. StockNews.com downgraded shares of InfuSystem from a "strong-buy" rating to a "buy" rating in a research report on Wednesday.

InfuSystem Trading Up 1.3%

Shares of INFU traded up $0.08 during trading hours on Monday, reaching $6.08. 22,359 shares of the company traded hands, compared to its average volume of 126,483. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50. The firm has a market cap of $127.78 million, a price-to-earnings ratio of 101.35 and a beta of 1.73. The stock's fifty day moving average price is $5.26 and its 200 day moving average price is $7.13. InfuSystem has a 12-month low of $4.61 and a 12-month high of $9.97.

Hedge Funds Weigh In On InfuSystem

A number of institutional investors have recently modified their holdings of the stock. Minerva Advisors LLC grew its holdings in InfuSystem by 7.5% during the first quarter. Minerva Advisors LLC now owns 910,677 shares of the company's stock worth $4,899,000 after acquiring an additional 63,826 shares during the period. First Eagle Investment Management LLC grew its stake in shares of InfuSystem by 25.9% during the 4th quarter. First Eagle Investment Management LLC now owns 908,371 shares of the company's stock worth $7,676,000 after purchasing an additional 186,668 shares during the period. Meros Investment Management LP increased its holdings in shares of InfuSystem by 2.6% during the 4th quarter. Meros Investment Management LP now owns 631,105 shares of the company's stock valued at $5,333,000 after purchasing an additional 16,178 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of InfuSystem by 5.0% in the 4th quarter. Dimensional Fund Advisors LP now owns 456,043 shares of the company's stock valued at $3,853,000 after purchasing an additional 21,697 shares during the period. Finally, Geode Capital Management LLC boosted its holdings in InfuSystem by 1.8% during the fourth quarter. Geode Capital Management LLC now owns 444,476 shares of the company's stock worth $3,756,000 after buying an additional 7,968 shares in the last quarter. Hedge funds and other institutional investors own 71.13% of the company's stock.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.